SCHEMBL8417646

SCHEMBL8417646

c1ccc(-c2nc(-c3ccccc3)n(CCCCN3CCN(c4ncccn4)CC3)c2-c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.49
HTR1A P08908 6/20 0.49
DRD2 P14416 5/20 0.49
DRD3 P35462 4/20 0.49
HTR7 P34969 3/20 0.49
DRD4 P21917 3/20 0.49
HTR2A P28223 3/20 0.49
ABCC1 P33527 1/20 0.48
SLC6A2 P23975 2/20 0.47
ADRA2A P08913 1/20 0.47
ADRA2C P18825 1/20 0.47
ADRA1A P35348 1/20 0.47
HRH1 P35367 1/20 0.47
HTR2B P41595 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
DRD1 P21728 1/20 0.46
DRD5 P21918 1/20 0.46
P2RX7 Q99572 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8417626 0.90 FAAH (0.51) SOAT1HTR1ADRD2DRD3HTR7
SCHEMBL8419683 0.79 PRKD3 (0.54) HTR1ADRD2DRD3HTR7DRD4
SCHEMBL8416338 0.76 P2RX7 (0.63) HTR1ADRD2DRD3HTR7DRD4
SCHEMBL8417628 0.76 HTR1A (0.51) HTR1ADRD2DRD3HTR7DRD4
SCHEMBL8416306 0.76 HTR1A (0.53) HTR1ADRD2DRD3HTR7DRD4
SCHEMBL8103848 0.73 BCHE (0.51)
SCHEMBL8418064 0.73 HTR1A (0.59) HTR1ADRD2DRD3HTR7DRD4
SCHEMBL8118190 0.73 BCHE (0.51)
SCHEMBL8112191 0.73 BCHE (0.51)
SCHEMBL8114738 0.73 BCHE (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
EP-0808166-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-11-26 EP claimed
WO-1997021439-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-06-19 WO claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP claimed